Options to Increase IVF Success
- Conditions
- Health Condition 1: Z318- Encounter for other procreative management
- Registration Number
- CTRI/2024/03/063849
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Predicted hyper-responders: fulfilling either of the three criteria, a. AFC more than 16,b. more than 13 follicles of more than 11 mm on day of GnRH agonist trigger, c.Serum estradiol levels more than 3500 pg per ml on day of trigger
GnRH antagonist cycles
Women aged 22 to less than 40 years
Unexplained infertility
Anovulatory infertility
Mild to moderate male factor infertility
more than 25 oocytes retrieved at ovum pick up
Signs of early onset OHSS
Any other contraindication to fresh ET
Known reasons for impaired implantation (i.e. hydrosalpinx, fibroid distorting the endometrial cavity, Asherman’s syndrome, thrombophilia or endometrial tuberculosis)
Previous 2 or more failed IVF
Patients who do not give written informed consent to participate
BMI less than 18 or more than 30Kg per m2
Cycles with frozen spermatozoa or oocytes
Oocyte donation cycles
Uterine anomalies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcome: Clinical pregnancy rate (Number of clinical pregnancies as determined by visualization of fetal cardiac activity on transvaginal ultrasound at 6–7weeks of gestation per embryo transfer cycles).Timepoint: at 6–7weeks of gestation per embryo transfer cycles
- Secondary Outcome Measures
Name Time Method